Google
ACXP — ACURX PHARMACEUTICALS LLC (Healthcare >> Biotechnology)
ACXP FAQ
What is ACXP's ROE?
ACURX PHARMACEUTICALS LLC reports a Return on Equity (ROE) of -106.92%.
What is ACXP's dividend yield?
ACURX PHARMACEUTICALS LLC offers a dividend yield of 0.00%.
What is ACXP's Deepscope Quality Score?
Deepscope rates ACXP's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ACXP?
Deepscope's AI Timing Score for ACXP is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ACXP belong to?
ACURX PHARMACEUTICALS LLC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 1.80
Price
-0.13
(-6.74%)
Day Change
|
|
|---|
ACXP, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 83 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.80 |
| PBV / Sector |
1.16 / 4.53
GREAT
|
| Earning Per Share | -1.66 |
| PE / Sector |
N/A / 16.80
|
| PEG or PE/Growth / Sector |
N/A / 0.51
|
| Average 1M Daily Value |
0.23 M
GREAT
|
| Average 1W Daily Value |
0.18 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
47% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-03 09:11:15 |
| Symbol | ACXP |
| Name | ACURX PHARMACEUTICALS LLC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 4.30 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 8.12 / 8,614.17 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 259 Liberty Avenue, Staten Island, NY, United States, 10305
Phone: 917 533 1469
Website: https://www.acurxpharma.com
Sector: Healthcare >> Biotechnology
Description: Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
